Tracense promotes the TS300M as a handheld, no-contact explosives trace detector using an air suction mechanism for rapid, standoff sampling and results within seconds.

The company markets a nanotechnology-based 'electronic nose' system capable of detecting ultra-low concentrations of explosives, biological warfare agents, toxic materials, drugs, and other contraband via odor profiles.

Tracense emphasizes replacing high-cost, labor-intensive explosives detection procedures with streamlined, modular, and largely non‑invasive trace detection solutions aimed at homeland security and defense users.

The firm describes its detectors as powered by ground-breaking nanotechnology innovations and positions them as best-in-class explosives detection systems.

Company materials and media coverage indicate an R&D focus on programmable nano-sensor arrays where each sensor stores specific odor profiles, enabling detection of a wide range of substances with lower false positives than traditional methods or trained dogs.

Public descriptions highlight potential dual-use applications of Tracense's sensing platform beyond security, including medical detection of bacteria, insulin, and sugar, although the company states it is currently concentrating on homeland security markets.

External profiles describe Tracense as offering solutions that enhance security outcomes and a 'safer tomorrow,' signaling a mission-driven culture oriented around safety and environmental responsibility.